ADESTO TECHNOLOGIES Corp Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q3 FY2015 As of Sep 30, 2015
Assets
Current assets:
Cash and cash equivalents
Short-term investments
Restricted cash
Accounts receivable, net
Inventories
Prepaid expenses
Deferred tax asset, current
Other current assets
Total current assets

Property and equipment, net
Deferred tax assets, non-current
Intangible assets, net
Other non-current assets
Operating lease right-of-use asset
Goodwill
Total assets

Liabilities and Equity
Current liabilities:
Accounts payable
Income taxes payable
Accrued compensation and benefits
Deferred tax liability, current
Accrued expenses and other current liabilities
Price adjustments and other revenue reserves
Earn-out liability, current
Line of credit, current
Operating lease liabilities, current
Term loan, current
Total current liabilities

Preferred stock warrant liability
Line of credit
Term loan, non-current
Convertible long-term debt
Operating lease liabilities, non-current
Deferred rent, non-current
Deferred tax liability, non-current
Other non-current liabilities
Total liabilities
Convertible preferred stock, no par value, no shares and 4,653,586 shares authorized as of December 31, 2015 and 2014; no shares and 4,419,853 shares issued and outstanding as of December 31, 2015 and 2014.
Stockholders’ equity:
Common stock, $0.0001 par value, 100,000,000 shares authorized; 30,268,685 and 29,442,065 shares issued and outstanding as of December 31, 2019 and 2018, respectively
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments